No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:29625000-29663600 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr6:29639600-29647400 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
3 |
chr6:29643000-29646400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
4 |
chr6:29643000-29648800 |
Enhancers |
HMEC |
breast
|
5 |
chr6:29643200-29648400 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
6 |
chr6:29643400-29648400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
7 |
chr6:29643800-29647600 |
Enhancers |
Fetal Heart |
heart
|
8 |
chr6:29644400-29645200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
9 |
chr6:29644400-29645400 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
10 |
chr6:29644400-29645600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
11 |
chr6:29644400-29646200 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
12 |
chr6:29644600-29645200 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
13 |
chr6:29644600-29645200 |
Enhancers |
Primary T helper cells fromperipheralblood |
blood
|
14 |
chr6:29644600-29645400 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
15 |
chr6:29644600-29645400 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
16 |
chr6:29644600-29645800 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
17 |
chr6:29644600-29646000 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
18 |
chr6:29644600-29647800 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
19 |
chr6:29644800-29645200 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
20 |
chr6:29644800-29645200 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
21 |
chr6:29644800-29645200 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
22 |
chr6:29644800-29645200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
23 |
chr6:29644800-29645400 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
24 |
chr6:29644800-29645400 |
Enhancers |
Primary T helper naive cells from peripheral blood |
blood
|
25 |
chr6:29644800-29645400 |
Enhancers |
GM12878-XiMat |
blood
|
26 |
chr6:29644800-29645400 |
Flanking Active TSS |
NHEK |
skin
|
27 |
chr6:29644800-29645600 |
Enhancers |
HUES48 Cell Line |
embryonic stem cell
|
28 |
chr6:29644800-29646200 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
29 |
chr6:29644800-29647400 |
Enhancers |
Hela-S3 |
cervix
|
30 |
chr6:29644800-29647600 |
Enhancers |
iPS-20b Cell Line |
embryonic stem cell
|
31 |
chr6:29644800-29648000 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
32 |
chr6:29644800-29648000 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
33 |
chr6:29645000-29645200 |
Enhancers |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
34 |
chr6:29645000-29645400 |
Enhancers |
Primary T helper cells PMA-I stimulated |
--
|
35 |
chr6:29645000-29646800 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
36 |
chr6:29645000-29648000 |
Weak transcription |
Primary monocytes fromperipheralblood |
blood
|